Diabetes, Digestive, and Kidney Diseases Extramural Research in Utah
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $89.2 million to recipients in Utah in 81 grants from fiscal 2021 to 2025, 0.9% of the program's national total. University of Utah received the most, $85.0 million.
- Awarded in Utah$89.2 million
- Awards81
- Share of the program0.9%
- Rank among states23rd of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 38 | $15.3 million |
| FY 2022 | 48 | $19.0 million |
| FY 2023 | 47 | $17.7 million |
| FY 2024 | 47 | $17.6 million |
| FY 2025 | 44 | $19.6 million |
Recipients in Utah
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Utah | Colleges and universities | 72 | $85.0 million |
| Brigham Young University | Colleges and universities | 4 | $2.0 million |
| Stream DX Inc | Small businesses | 1 | $983,074 |
| D Biotherapeutics, LLC | Small businesses | 2 | $601,469 |
| Evincis Bio, Inc. | Small businesses | 1 | $310,780 |
| N8 Medical Inc | Small businesses | 1 | $299,155 |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Utah?
$89.2 million from fiscal 2021 to 2025, across 81 awards. Utah ranks 23rd of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Utah?
The largest recipient is University of Utah, with $85.0 million in 72 awards. Next are Brigham Young University and Stream DX Inc.
Can organizations in Utah apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Utah
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- Children's Health Insurance Program
- Head Start
- Federal Transit Formula Grants